The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Ocular Implants Global Market Report 2024, the ocular implants market is expected to show significant growth in the forecast period.

1. Introduction

The ocular implants market has experienced rapid expansion in recent years, setting the stage for substantial growth in the near future. In 2023, the market size stood at $13.57 billion, projected to reach $15.14 billion in 2024 with a robust CAGR of 11.6%. Looking ahead, the forecast indicates further acceleration, with the market expected to surge to $22.96 billion in 2028, boasting a CAGR of 11.0%. This flourishing trajectory is attributed to various factors, including the aging global population, the prevalence of myopia, glaucoma management, minimally invasive surgery, and a commitment to patient safety.

2. Geriatric Boom Driving Market Expansion
3. Geriatric Population and Eye Health

• Ocular implants cater to age-related eye conditions like cataracts, glaucoma, and presbyopia.
• Enhances vision, reduces reliance on corrective eyewear, and improves the quality of life for older individuals.

1. Global Aging Trends

• According to the World Health Organization, the global population aged 60 years is projected to reach 1.4 billion by 2022.
• One out of six people worldwide will be aged 60 or older by 2030.

1. Market Players

• Major companies in the ocular implants market include Alcon Inc., Bausch & Lomb Inc., Carl Zeiss AG, and Johnson and Johnson Services Inc.

View More On The Ocular Implants Market Report 2024 – https://www.thebusinessresearchcompany.com/report/ocular-implants-global-market-report

3. Innovative Ocular Implant Products Reshaping Care
4. Premium Iris Implant Products

• Major companies are introducing premium-quality iris implant products for a competitive edge.
• Example: HumanOptics Holding AG’s ARTIFICIALIRIS SELECT offers customizable iris replacement, allowing surgeons to select from a range of colors for efficient patient care.

4. Strategic Moves in the Industry
5. Alcon’s Acquisition of Ivantis

• In August 2021, Alcon acquired Ivantis for $475 million in cash.
• Demonstrates Alcon’s commitment to the surgical glaucoma market.
• Strengthens Alcon’s position in cataract, refractive, retina, and glaucoma segments.

5. Market Segmentation and Regional Insights

• Segmentation:
  1. By Product: Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants, Other Products
  2. By Application: Glaucoma Surgery, Diabetic Retinopathy, Age-Related Macular Degeneration
  3. By End-User: Specialty Eye Institutes, Hospitals, Clinics
• Regional Insights:

• • North America led the ocular implants market in 2023.
  • Asia-Pacific is anticipated to be the fastest-growing region in the forecast period.

6. Conclusion

The ocular implants market is not only witnessing remarkable growth but is also undergoing transformative changes with technological advancements, ophthalmic innovation, and the integration of digital healthcare and artificial intelligence. As major players introduce cutting-edge products and engage in strategic acquisitions, the landscape of ocular care is evolving. The surge in the aging population and a growing emphasis on patient safety further emphasize the need for continuous innovation in this dynamic sector. Stakeholders in the ocular implants market must remain vigilant to capitalize on emerging trends and contribute to the evolution of eye care solutions.

Request A Sample Of The Global Ocular Implants Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6557&type=smp